You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指新貴藥明生物(02269.HK)小米(01810.HK)漲5%-8% 惟阿里續軟 染藍大熱倒灶美團倒升
阿思達克 08-17 11:54
3隻恆指新貴及被剔出3隻成份股今早個別發展,小米集團-W(01810.HK)表現最好,股價四連漲,最高見16.66元,現造16.56元,急漲8%,成交增至1.93億股,涉資31.51億元。藥明生物(02269.HK)重越10天線(166元),最高見171.5元,現造169.5元,回升5%;但阿里巴巴-SW(09988.HK)連續兩天受壓,最低見241.2元,現造245.2元,續跌0.6%。此外,被剔出恆指成份股的信置(00083.HK)及旺旺(00151.HK)逆跌逾2%,前者失守10天及20天線,最低見9.18元,現造9.26元,回吐3%;後者曾一舉失守50天、10天及20天線(5.72元/5.8元/5.83元),最低見5.69元,現造5.73元,續吐2.5%;但神華(01088.HK)反覆重越10天及20天線(12.9元及13.05元),高低見13.12元/12.62元,現造13.06元,反覆回升1.5%。

「染藍」大熱倒灶只獲納入國企成份股的美團點評-W(03690.HK)曾失守10天線(21.8.7元),急吐4.9%低見209元獲承接,掉頭高見221.8元,現造221.4元,倒升0.7%。此外,被剔出國企成份股的中信証券(06030.HK)隨A股(漲5.8%曾高見33.28元人民幣)續升5.1%報19.3元,股價重越10天及20天線,同被剔出國企的國藥(01099.HK)續升2.1%報19.18元,股價重越10天線(18.98元),但被剔出國企成份股的比亞迪(01211.HK)反覆吐1.2%報72.6元。

恆生指數公司上周五收市後宣布季度檢討結果,恆指指成分股新納入小米、藥明生物及阿里巴巴-SW,以代替被剔出信置、旺旺及神華,成份股總數維持50隻。另外,恆生中國企業指數新納入小米、美團點評及阿里巴巴,取代初剔出國藥、比亞迪及中信証券,成份股總數目維持50隻。上述所有變動9月7日(星期一)起生效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account